Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer Bolt Medical.

Vantis Vascular announced today announced the first commercial use of its CrossFast integrated microcatheter advanced delivery system.

Boston Scientific Corp. is paying $443 million upfront, plus up to $221 million in possible milestones, to buy the remainder ...

These devices are used to secure the peripheral catheter of Clik-FIX. Shockwave Medical Inc. announced in March 2022 that the Shockwave M5+ peripheral IVL catheter, which has a CE Mark and FDA ...

Vantis Vascular, Inc., a pioneering medical technology company founded by physicians with a passion to revolutionize vascular ...

By developing IVL catheters that are more deliverable, with greater precision and more energy availability, we hope to empower interventionalists with better options so more of their patients can ...

PORTLAND, OR, UNITED STATES, January 6, 2025 /EINPresswire / -- The global shockwave therapy market is experiencing significant growth, with its size valued at approximately $1,171.19 million in ...

Bolt Medical is focused on the design and development of laser-based IVL catheters used in coronary and peripheral interventional procedures, particularly in patients with moderate to severe calcified ...